tiprankstipranks
Savara Partners with Fujifilm for Molgramostim Development
Company Announcements

Savara Partners with Fujifilm for Molgramostim Development

Savara (SVRA) has released an update.

Pick the best stocks and maximize your portfolio:

Savara Inc. has solidified its partnership with Fujifilm’s biotech divisions to advance the development and manufacturing of the active pharmaceutical ingredient for its molgramostim product candidate. This collaboration is outlined in a Master Services Agreement, supplemented by specific work scopes, the first of which involves a significant manufacturing campaign. The agreement, which is detailed for legalities like confidentiality and dispute resolution, allows for termination under certain conditions, ensuring flexibility and protection for both entities as they navigate the intricate process of bringing a pharmaceutical product to market.

For further insights into SVRA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlySavara initiated with an Overweight at Wells Fargo
TheFlySavara initiates rolling submission of BLA to FDA for MOLBREEVI
TheFlySavara downgraded to In Line from Outperform at Evercore ISI
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App